Cargando…
Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it
Autores principales: | Trestini, I., Caldart, A., Dodi, A., Avancini, A., Tregnago, D., Sartori, G., Belluomini, L., Milella, M., Pilotto, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027687/ https://www.ncbi.nlm.nih.gov/pubmed/33773420 http://dx.doi.org/10.1016/j.esmoop.2021.100095 |
Ejemplares similares
-
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?
por: Belluomini, Lorenzo, et al.
Publicado: (2020) -
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned
por: Belluomini, Lorenzo, et al.
Publicado: (2021) -
Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study
por: Avancini, Alice, et al.
Publicado: (2022) -
Physical Activity for Oncological Patients in COVID-19 Era: No Time to Relax
por: Avancini, Alice, et al.
Publicado: (2020) -
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done
por: Belluomini, Lorenzo, et al.
Publicado: (2021)